Financhill
Back

Embecta 10K Form

Buy
87

EMBC
Embecta

Last Price:
20.12
Seasonality Move:
-15.29%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EMBC News And Ratings

See the #1 stock for the next 7 days that we like better than EMBC

EMBC Financial Statistics

Sales & Book Value

Annual Sales: $1.12B
Cash Flow: $26.6M
Price / Cash Flow: 60.02
Annual Sales: $-12.79
Price / Book: 0

Profitability

EPS (TTM): 1.35000
Net Income (TTM): $78.3M
Gross Margin: $735.2M
Return on Equity: 0%
Return on Assets: 6.33%

Embecta Earnings Forecast

Key Embecta Financial Ratios

  • The Gross Profit Margin over the past 6 years for EMBC is 65.46%.
  • The Selling, General & Administrative Expenses for EMBC have been equal to 32.51% of Gross Profit Margin.
  • The Research & Development expenses have been 7.02% of Revenue.
  • The Interest Expense is 143.42% of Operating Income.
  • The Net Earning history of EMBC is 6.97% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 1 years.

Embecta Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: EMBC
Website: embecta.com

Debt

Debt-to-Equity Ratio: -2.13
Current Ratio: 2.03
Quick Ratio: 1.38

Price-to-Earnings

Trailing P/E Ratio: 15.39
Forward P/E Ratio: 8.23

EMBC Technical Analysis vs Fundamental Analysis

Buy
87
Embecta (EMBC) is a Buy

Is Embecta a Buy or a Sell?

  • Embecta stock is rated a Buy
    The current Embecta [EMBC] share price is $20.62. The Score for EMBC is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.